Source: Annual Congress 2004 - Diagnosis and epidemiology of respiratory infections in the ICU
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. B. Lazareva, V. V. Arkhipov (Moscow, Russia). Epidemiology of antibiotics prescribtion for treatment of hospital-acquired pnemonia (HAP) in ICU. Eur Respir J 2004; 24: Suppl. 48, 3387

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Epidemiology of community-acquired pneumonia (CAP) Source: International Congress 2015 – Russia Day: Community-acquired pneumonia (CAP) in adults Year: 2015 Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002 Prior antibiotics and outcomes in patients hospitalized with pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Epidemiology of community- and hospital-acquired pneumonia Source: Annual Congress 2003 - PG11 - Pneumonia epidemiology and diagnosis Year: 2003 Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Emergency treatment of communityacquired pneumonia Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=183 Year: 2006 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Antibiotic treatment for nosocomial pneumonia Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211 Year: 2004 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Guideline 2017 Year: 2017 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017 Year: 2017 Etiological features of nosocomial pneumonia in neurosurgical intensive care unit Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Oral antibiotics prior to hospitalisation for community-acquired pneumonia Source: Eur Respir J 2008; 31: 478-479 Year: 2008 Epidemiology of nosocomial pneumonia (NP) in patients of general surgical departments Source: Eur Respir J 2005; 26: Suppl. 49, 144s Year: 2005 Microbiological vs non-microbiological confirmed nnventilator ICU-acquired pneumonia Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013